On Friday, B.Riley maintained a positive outlook on Performant Financial (NASDAQ:PFMT), keeping a Buy rating and an $8.00 price target for the stock. The firm’s stance comes in light of Performant Healthcare Solutions, a division of Performant Financial, securing a significant three-year contract for Medicaid Recovery Audit Contractor Services, set to commence on April 7, 2025.
This development marks a notable achievement for the company as it successfully displaces the previous nine-year holder of the contract, HMS/Veritas Capital, which had a total contract value of $139.5 million.
The new contract implies an annual value of approximately $15.5 million. However, it is noted that reaching full scale may take over 12 months. The victory for Performant Financial is seen as pivotal, as it not only unseats the incumbent but also establishes an initial presence in the state Medicaid market.
The company estimates this market could represent a revenue opportunity ranging from $300 million to $500 million. For context, the federal and commercial markets present opportunities of $500 million to $1 billion and $3.2 billion to $3.5 billion, respectively.
The analyst from B.Riley underscored the importance of this contract win, stating that it is a “massive win for the company.” The analyst’s reiteration of the Buy rating and price target reflects confidence in Performant Financial’s potential growth following this new contract. The Medicaid Recovery Audit Contractor Services project is expected to be a strategic entry point for Performant Financial into a lucrative market segment, which could significantly contribute to the company’s revenue stream in the coming years.
In other recent news, Performant Financial Corporation has announced significant growth in its Q1 2024 earnings, accompanied by a substantial increase in year-over-year revenue.
The company initiated 10 new programs with existing clients, which are expected to generate an annualized revenue between $5 million and $6 million. In addition to these financial highlights, Performant has also won a tentative New York State Medicaid Recovery Audit Contractor (RAC) award, reinforcing its established presence in the government sector.
Performant’s eligibility and clinical audit businesses reported growth rates of 7% and 19% respectively. The company also disclosed the acquisition of RecordsOne, a move aimed at enhancing audit workflow processes. These are among the recent developments that demonstrate Performant’s strategic initiatives to sustain growth and enhance operational efficiency.
In governance news, during its Annual Meeting of Stockholders, Lisa C. Im and Bradley M. Fluegel were elected as Class III directors. The company’s independent auditor, Baker Tilly US, LLP, was ratified for the fiscal year ending December 31, 2024. Shareholders also approved amendments to the company’s 2012 Stock Incentive Plan and the 2024 Employee Stock Purchase Plan.
Despite operating expenses of $31.3 million, Performant’s adjusted EBITDA surpassed expectations at negative $1.2 million. The company maintains its full-year guidance, projecting healthcare revenues between $117 million and $120 million, and total company revenue ranging from $124 million to $129 million.
InvestingPro Insights
As Performant Financial (NASDAQ:PFMT) garners attention with its new Medicaid Recovery Audit Contractor Services contract, InvestingPro data provides additional context to their financial standing. With a market capitalization of $277.88 million and a revenue growth of 10.77% over the last twelve months as of Q2 2024, the company shows a notable upward trajectory. However, investors should note the company’s P/E ratio stands at -42.05, reflecting its current lack of profitability. Despite this, Performant Financial has been trading near its 52-week high, with a price 94.74% of that peak, suggesting investor optimism.
Among the InvestingPro Tips, it’s worth highlighting that analysts do not expect the company to be profitable this year, which aligns with the negative P/E ratio. Nonetheless, Performant Financial’s liquid assets exceed short-term obligations, indicating a stable financial position to meet immediate liabilities. Additionally, the company operates with a moderate level of debt, which may offer some reassurance to risk-averse investors. For those looking for more in-depth analysis, there are additional InvestingPro Tips available at https://www.investing.com/pro/PFMT.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
